Profile | GDS5420 / 244377_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 358.36 | 62 |
GSM1296119 | B_lesional_pre-dose | 250.58 | 56 |
GSM1296076 | C_lesional_pre-dose | 283.74 | 60 |
GSM1296092 | D_lesional_pre-dose | 350.43 | 63 |
GSM1296103 | E_lesional_pre-dose | 312.38 | 60 |
GSM1296078 | F_lesional_pre-dose | 286.34 | 60 |
GSM1296107 | G_lesional_pre-dose | 287.46 | 58 |
GSM1296109 | H_lesional_pre-dose | 269.98 | 56 |
GSM1296080 | I_lesional_pre-dose | 374.57 | 63 |
GSM1296090 | J_lesional_pre-dose | 276.69 | 59 |
GSM1296074 | K_lesional_pre-dose | 301.21 | 61 |
GSM1296111 | L_lesional_pre-dose | 265.22 | 56 |
GSM1296099 | M_lesional_pre-dose | 248.76 | 56 |
GSM1296086 | O_lesional_pre-dose | 298.15 | 60 |
GSM1296117 | P_lesional_pre-dose | 226.88 | 54 |
GSM1296113 | Q_lesional_pre-dose | 309.16 | 59 |
GSM1296096 | R_lesional_pre-dose | 285.49 | 58 |
GSM1296105 | S_lesional_pre-dose | 258.31 | 56 |
GSM1296098 | T_lesional_pre-dose | 812.7 | 76 |
GSM1296101 | U_lesional_pre-dose | 625.76 | 71 |
GSM1296121 | V_lesional_pre-dose | 309.37 | 59 |
GSM1296088 | W_lesional_pre-dose | 353.9 | 62 |
GSM1296082 | X_lesional_pre-dose | 252.69 | 58 |
GSM1296115 | Y_lesional_pre-dose | 264 | 57 |
GSM1296084 | Z_lesional_pre-dose | 541.15 | 69 |
GSM1296072 | B_lesional_day8 | 356.82 | 62 |
GSM1296069 | L_lesional_day8 | 425.87 | 64 |
GSM1296071 | P_lesional_day8 | 274.53 | 56 |
GSM1296070 | Y_lesional_day8 | 376.97 | 62 |
GSM1296073 | V_lesional_day8 | 325.67 | 61 |
GSM1296034 | A_lesional_day15 | 676.63 | 72 |
GSM1296041 | G_lesional_day15 | 285.38 | 58 |
GSM1296035 | R_lesional_day15 | 307.48 | 59 |
GSM1296038 | U_lesional_day15 | 372.93 | 63 |
GSM1296047 | B_lesional_day15 | 400.62 | 64 |
GSM1296039 | E_lesional_day15 | 452.82 | 67 |
GSM1296042 | H_lesional_day15 | 329.57 | 60 |
GSM1296043 | L_lesional_day15 | 331.26 | 60 |
GSM1296037 | M_lesional_day15 | 415.83 | 64 |
GSM1296046 | P_lesional_day15 | 407.24 | 64 |
GSM1296044 | Q_lesional_day15 | 474.69 | 66 |
GSM1296045 | Y_lesional_day15 | 431.35 | 65 |
GSM1296025 | C_lesional_day15 | 633.19 | 72 |
GSM1296033 | D_lesional_day15 | 517.49 | 68 |
GSM1296027 | I_lesional_day15 | 429.14 | 66 |
GSM1296032 | J_lesional_day15 | 628.37 | 71 |
GSM1296024 | K_lesional_day15 | 674.99 | 73 |
GSM1296031 | W_lesional_day15 | 594.76 | 70 |
GSM1296028 | X_lesional_day15 | 575.26 | 70 |
GSM1296029 | Z_lesional_day15 | 625.68 | 71 |
GSM1296026 | F_lesional_day15 | 342.8 | 62 |
GSM1296030 | O_lesional_day15 | 436.96 | 66 |
GSM1296040 | S_lesional_day15 | 362.72 | 62 |
GSM1296036 | T_lesional_day15 | 629.67 | 71 |
GSM1296048 | V_lesional_day15 | 404.07 | 64 |
GSM1296059 | A_lesional_day43 | 273.05 | 58 |
GSM1296066 | G_lesional_day43 | 284.09 | 58 |
GSM1296060 | R_lesional_day43 | 439.75 | 65 |
GSM1296063 | U_lesional_day43 | 351.04 | 62 |
GSM1296064 | E_lesional_day43 | 338.56 | 62 |
GSM1296067 | H_lesional_day43 | 332.38 | 59 |
GSM1296062 | M_lesional_day43 | 462.25 | 66 |
GSM1296068 | Q_lesional_day43 | 378.02 | 62 |
GSM1296050 | C_lesional_day43 | 371.69 | 63 |
GSM1296057 | D_lesional_day43 | 511.09 | 68 |
GSM1296052 | I_lesional_day43 | 450.01 | 66 |
GSM1296054 | J_lesional_day43 | 798.46 | 75 |
GSM1296049 | K_lesional_day43 | 516.67 | 68 |
GSM1296055 | W_lesional_day43 | 456.94 | 66 |
GSM1296053 | X_lesional_day43 | 668.19 | 72 |
GSM1296058 | Z_lesional_day43 | 496.6 | 67 |
GSM1296051 | F_lesional_day43 | 283.04 | 59 |
GSM1296056 | O_lesional_day43 | 545.4 | 69 |
GSM1296065 | S_lesional_day43 | 275.99 | 57 |
GSM1296061 | T_lesional_day43 | 587.9 | 70 |
GSM1296095 | A_non-lesional_pre-dose | 368.59 | 63 |
GSM1296120 | B_non-lesional_pre-dose | 376.95 | 63 |
GSM1296077 | C_non-lesional_pre-dose | 551.71 | 70 |
GSM1296093 | D_non-lesional_pre-dose | 918.71 | 78 |
GSM1296104 | E_non-lesional_pre-dose | 414.91 | 65 |
GSM1296079 | F_non-lesional_pre-dose | 421.59 | 65 |
GSM1296108 | G_non-lesional_pre-dose | 529.6 | 69 |
GSM1296110 | H_non-lesional_pre-dose | 355.52 | 61 |
GSM1296081 | I_non-lesional_pre-dose | 505.58 | 68 |
GSM1296091 | J_non-lesional_pre-dose | 374.75 | 63 |
GSM1296075 | K_non-lesional_pre-dose | 475.4 | 68 |
GSM1296112 | L_non-lesional_pre-dose | 330.17 | 59 |
GSM1296100 | M_non-lesional_pre-dose | 815.67 | 76 |
GSM1296087 | O_non-lesional_pre-dose | 594.04 | 71 |
GSM1296118 | P_non-lesional_pre-dose | 341.51 | 60 |
GSM1296114 | Q_non-lesional_pre-dose | 423.45 | 64 |
GSM1296097 | R_non-lesional_pre-dose | 468.25 | 67 |
GSM1296106 | S_non-lesional_pre-dose | 468.19 | 66 |
GSM1296102 | U_non-lesional_pre-dose | 878.61 | 77 |
GSM1296122 | V_non-lesional_pre-dose | 324.11 | 60 |
GSM1296089 | W_non-lesional_pre-dose | 685.31 | 73 |
GSM1296083 | X_non-lesional_pre-dose | 574.41 | 70 |
GSM1296116 | Y_non-lesional_pre-dose | 358.97 | 61 |
GSM1296085 | Z_non-lesional_pre-dose | 684.17 | 73 |